Relafen 750, a novel formulation for naproxen, presents an intriguing case from a biochemical pharmacy lens. Its enhanced absorption and regular naproxen preparations suggests an altered metabolic process leading to conceivably increased therapeutic benefit in patients experiencing inflammatory pain . Additional investigation into this uptake and e